https://doi.org/10.1038/ng.3899
G
Godelieve A.M. Tytgat
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
194
Papers
5.3K
Citations
35
h-index
88
i10-index
Godelieve A.M. Tytgat is an academic researcher. The author has contributed to research in topics: Neuroblastoma Research and Treatments & Cancer, Hypoxia, and Metabolism & Renal and related cancers. The author has an h-index of 35, co-authored 165 publications.
ORCID: 0000-0003-2356-5197Papers by this author
worksNeuroblastoma is composed of two super-enhancer-associated differentiation states
2017 · Nature Genetics · 554 citations
An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity
2020 · Nature Communications · 301 citations
https://doi.org/10.1038/s41467-020-15155-6
The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review
2020 · European Journal of Pediatrics · 67 citations
https://doi.org/10.1007/s00431-019-03545-y
Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma
2009 · Cellular and Molecular Life Sciences · 58 citations
https://doi.org/10.1007/s00018-009-0212-2
Is complete surgical resection of stage 4 neuroblastoma a prerequisite for optimal survival or may >95 % tumour resection suffice?
2012 · Pediatric Surgery International · 43 citations
https://doi.org/10.1007/s00383-012-3109-3
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis
2014 · European Journal of Nuclear Medicine and Molecular Imaging · 20 citations
https://doi.org/10.1007/s00259-014-2909-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat